The artificial intelligence (AI) in drug discovery market report from The Business Research Company covers growth-driving insights such as AI in drug discovery market size, AI in drug discovery market trends and drivers, AI in drug discovery market segmentation, AI in drug discovery market competitive landscape and more

The artificial intelligence (AI) in drug discovery market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 30%, as per The Business Research Company’s market report!

Read More On The Artificial Intelligence (AI) In Drug Discovery Market Report 2022 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

The Artificial Intelligence (AI) In Drug Discovery Market Size In 2022 And Forecast

The global artificial intelligence (AI) in drug discovery market is expected to grow from $791.83 million in 2021 to $1042.30 million in 2022 at a compound annual growth rate (CAGR) of 31.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The artificial intelligence (AI) in drug discovery market is expected to reach $2994.52 million in 2026 at a CAGR of 30.2%.

The artificial intelligence (AI) in drug discovery market consists of sales of AI for drug discovery and related services. Artificial Intelligence (AI) for drug discovery is a technology that uses a simulation of human intelligence process by machines to tackle complex problems in the drug discovery process.

Request for A Sample Of The Global Artificial Intelligence (AI) In Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6078&type=smp

The Rise In Demand For A Reduction In The Overall Time Taken For The Drug Discovery Is Driving The Growth Of The Artificial Intelligence (AI) In Drug Discovery Market

For instance, in 2020, the British start-up Exscientia and Japan’s Sumitomo Dainippon Pharma have used artificial intelligence to produce an obsessive-compulsive disorder (OCD) medication, decreasing the development time from four years to less than one year. The reduction in overall time taken for the drug discovery process drives the artificial intelligence (AI) in drug discovery market’s growth.

Competitive Landscape And The Regional Analysis Of The Artificial Intelligence (AI) In Drug Discovery Market

Major players in the artificial intelligence (AI) in drug discovery market are BM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE.

The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the artificial intelligence (AI) in drug discovery market.

Strategic Collaborations – A Key Trend In The Artificial Intelligence (AI) In Drug Discovery Market

Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market.

Artificial Intelligence (AI) In Drug Discovery Market Segmentation By The Business Research Company

1) By Technology: Deep Learning, Machine Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others

4) By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Others

Here Are Some Reports Related To The Artificial Intelligence (AI) In Drug Discovery Market –

Artificial Intelligence In Healthcare Global Market Report 2022

Healthcare Services Global Market Report 2022

Telehealth Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: